Division of Johnson & Johnson
Latest From SterilMed Inc.
Market Brief: The Need For Safer Needles, Syringes Will Drive Global Injection Devices Market Growth By 2023
Accelerating technological innovation, reimbursement and legislative changes are expected to make a significant impact on the global market of injection devices and related products. According to Informa's new Meddevicetracker report on "Infection Control and Biosafety Products," the combined market of these devices will reach $4bn by 2023.
Improper reprocessing may pose a risk of air embolism due to a leaky valve, FDA said in the recall announcement.
The US market for infection control and biosafety products will see strong growth ahead as hospitals continue the battle against health care-associated infections with innovative products and services designed to prevent needlesticks, nosocomial infections, and the spread of antibiotic-resistant organisms.
The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.
- Surgical Equipment & Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Johnson & Johnson
- Senior Management
- Mike Gustafson, Pres.
- Contact Info
Phone: (888) 856-4870
11400 73rd Ave. N
Maple Grove, MN 55369
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.